Polyrizon Prices $4.2 Million IPO

MT Newswires Live10-29

Polyrizon (PLRZ) said Monday that it priced its underwritten initial public offering of 958,903 units at $4.38 per unit for expected gross proceeds of $4.2 million.

Each unit consists of one ordinary share and three warrants to buy one ordinary share per warrant, with an initial exercise price of $4.38 per share.

The company also granted Aegis Capital a 45-day option to buy up to 143,835 additional units to cover possible over-allotments. The offering is expected to close on or about Wednesday.

The company said it plans to use net proceeds to fund preclinical and clinical development of its product candidates, other research and development, repayment of certain outstanding debt, working capital, general corporate purposes and possible future acquisitions.

Polyrizon also said that its ordinary shares have been approved for listing and are expected to start trading on the Nasdaq Capital Market under the symbol "PLRZ" on Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment